128.151.71.19
no edit summary
+700
128.151.71.19
no edit summary
+42
128.151.71.19
no edit summary
+1
128.151.71.19
no edit summary
+1,221
128.151.71.19
no edit summary
+5
128.151.71.19
no edit summary
+837
128.151.71.19
no edit summary
+1
128.151.71.19
no edit summary
+75
128.151.71.19
no edit summary
+3
66.67.59.249
no edit summary
+12
66.67.59.249
→Reasons for Hair loss
-12
66.67.59.249
→Reasons for Hair loss
+8
66.67.59.249
→Reasons for Hair loss
+4
66.67.59.249
no edit summary
+304
66.67.59.249
no edit summary
+24
66.67.59.249
no edit summary
+9
66.67.59.249
no edit summary
-10
66.67.59.249
no edit summary
-9
66.67.59.249
no edit summary
-11
66.67.59.249
no edit summary
+123
66.67.59.249
no edit summary
+207
66.67.59.249
no edit summary
-1
66.67.59.249
no edit summary
+289
65.209.251.77
→New opportunities
+16
Vinod.singh@dolcera.com
no edit summary
Vinod.singh@dolcera.com
no edit summary
+114
210.214.44.168
→Inhibition of 5- - reductase by Finasteride
+3
Vinod.singh@dolcera.com
→Inhibition of 5- - reductase by Finasteride
+41
Vinod.singh@dolcera.com
→GSK3 inhibition by pryazole pyrimidine amine derivatives
-46
Vinod.singh@dolcera.com
→GSK3 inhibition by pryazole pyrimidine amine derivatives
+595
Vinod.singh@dolcera.com
→Structure-Activity Relationships (SARs) of Finasteride
-14
Vinod.singh@dolcera.com
→Structure-Activity Relationships (SARs) of Finasteride
+36
210.214.27.65
→GSK3 inhibition by pryazole pyrimidine amine derivatives
+19,458
210.214.27.65
no edit summary
+181
210.214.27.65
→GSK3 inhibition by pyrazole compounds
-21
210.214.27.65
→GSK3 inhibition by pyrazole compounds
-103
210.214.27.65
→GSK3 inhibition by pyrazole compounds
+1,201
Aziz
no edit summary
Aziz
no edit summary
Aziz
no edit summary
-18
Aziz
no edit summary
-16
Aziz
no edit summary
+3
Aziz
no edit summary
-18
Aziz
no edit summary
+2,140
Aziz
no edit summary
-6
Aziz
no edit summary
+3
Aziz
no edit summary
+627
Aziz
no edit summary
+991